lazertinib,amivantamab
janssen,yuhan corp
['lcsm,(-blcsm)', 'amivantamab', 'lazertinib']
durable responses with amivantamab + lazertinib in the #met subgroup but baseline ngs of cdna not predictive of response to amivantamab + lazertinib #asco23 #lcsm 
#HemeOnc @LombardiCancer |@EmoryDeptofMed @GradyHealth @tulanemedicine |#MedEd #clinicaltrials #disparities #lcsm 🎶🎤|🐱mom|she/her⚜️🏠#504 tweetsmyown